Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,000 | 0 | 0 | 1,650 | 2,300 |
| Marketable Securities | 0 | 0 | 0 | 0 | 7 |
| Receivables | 620 | 0 | 0 | 430 | 400 |
| Inventories | 650 | 0 | 0 | 580 | 720 |
| Other current assets | 15 | 0 | 0 | 160 | 11 |
| TOTAL | $2,420 | $0 | $0 | $2,820 | $3,600 |
| Non-Current Assets | |||||
| PPE Net | 2,300 | N/A | N/A | N/A | 2,240 |
| Other Non-Current Assets | 20 | 0 | 0 | 20 | 20 |
| TOTAL | $2,320 | $N/A | $N/A | $20 | $2,260 |
| Total Assets | $2,650 | $0 | $0 | $3,170 | $4,030 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 450 | 0 | 0 | 1,010 | 980 |
| Accrued Expenses | 230 | 0 | 0 | 390 | 510 |
| TOTAL | $690 | $0 | $0 | $1,410 | $1,500 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $690 | $0 | $0 | $1,410 | $1,500 |
| Shareholders' Equity | |||||
| Common Shares | 40 | 0 | 0 | 30 | 30 |
| Retained earnings | -89,970 | 0 | 0 | -88,680 | -87,940 |
| Other shareholders' equity | 70 | 0 | 0 | 30 | 70 |
| TOTAL | $1,950 | $0 | $0 | $1,760 | $2,530 |
| Total Liabilities And Equity | $2,640 | $0 | $0 | $3,170 | $4,030 |